Estrella Immunopharma, Inc. Annual Return On Equity in % from 2021 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Estrella Immunopharma, Inc. quarterly/annual Return On Equity history and growth rate from 2021 to 2022.
  • Estrella Immunopharma, Inc. Return On Equity for the quarter ending March 31, 2024 was -86.6 %, a 151% decline year-over-year.
  • Estrella Immunopharma, Inc. annual Return On Equity for 2022 was 31.9 %, a 41% decline from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 31.9 -22.2 -41% Jan 1, 2022 Dec 31, 2022
2021 54.1 Jan 6, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.